持续气道正压治疗对睡眠呼吸暂停患者血压控制决定因素的影响
该交叉随机试验纳入32例新诊断高血压且未接受降压治疗的阻塞性睡眠呼吸暂停患者,随机接受12周CPAP或假CPAP治疗,评估外周化学敏感性、肾素-血管紧张素-醛固酮系统活性、交感张力及内皮生物标志物的夜间变化。结果显示CPAP仅降低孤立性夜间高血压患者外周化学敏感性的夜间升高幅度,并纠正日间-夜间持续高血压患者的高日间敏感性。
要点
- CPAP可降低孤立性夜间高血压患者外周化学敏感性的夜间升高。
- CPAP可纠正日间-夜间持续高血压患者的高日间外周化学敏感性。
- 两类高血压患者对CPAP的反应差异有助于理解OSA高血压持续机制。
核心结论
- CPAP降低孤立性夜间高血压患者外周化学敏感性的夜间升高,并纠正日间-夜间持续高血压患者的高日间敏感性。
研究设计与样本
- 交叉随机试验纳入32例新诊断高血压且未接受降压治疗的OSA患者,随机分配至12周CPAP或假CPAP。
- 外周化学敏感性通过睡眠前后低氧撤退试验(%ΔVI)评估。
主要发现
- 基线时日间-夜间持续高血压患者睡前%ΔVI更高,醛固酮和日间儿茶酚胺水平更高。
- CPAP仅降低孤立性夜间高血压患者%ΔVI的夜间升高(6.9%,95%CI 1.0-12.8%;p=0.026)。
- CPAP诱导的睡眠后%ΔVI较基线变化在孤立性夜间高血压组为7.5%(95%CI 2.6-12.2%,p=0.005),在日间-夜间持续高血压组为5.7%(95%CI 2.2-9.3%,p=0.004)。
- 睡前%ΔVI仅在日间-夜间持续高血压患者中随CPAP降低(3.0%,95%CI 0.5-5.6%;p=0.023)。
临床怎么用
- 对OSA合并高血压患者,CPAP对血压调节机制的改善可能因高血压亚型而异。
- 孤立性夜间高血压与日间-夜间持续高血压患者对CPAP的外周化学敏感性反应不同,提示需个体化评估。
局限性
- 样本量较小(32例),结果需更大样本验证。
- 研究仅评估12周CPAP效果,长期影响未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our aim was to assess the effect of continuous positive airway pressure (CPAP) on the nocturnal evolution of peripheral chemosensitivity, renin-angiotensin-aldosterone system activity, sympathetic tone and endothelial biomarkers in obstructive sleep apnoea (OSA) patients with isolated nocturnal hypertension (INH) or day-night sustained hypertension (D-NSH).In a crossover randomised trial, 32 OSA patients newly diagnosed with hypertension and without antihypertensive treatment were randomly assigned to 12 weeks of CPAP or sham CPAP. Peripheral chemosensitivity was evaluated before and after sleep using the hypoxic withdrawal test (%ΔVI).At baseline, D-NSH patients showed higher %ΔVI before sleep and higher levels of aldosterone and diurnal catecholamines. CPAP only reduced the nocturnal increase of %ΔVI in INH patients (6.9%, 95% CI 1.0-12.8%; p=0.026). CPAP-induced change from baseline in %ΔVI after sleep was 7.5% (95% CI 2.6-12.2%, p=0.005) in the INH group and 5.7% (95% CI 2.2-9.3%, p=0.004) in the D-NSH group. In contrast, %ΔVI before sleep only decreased with CPAP in the D-NSH patients (3.0%, 95% CI 0.5-5.6%; p=0.023).In conclusion, CPAP reduces the nocturnal increase of peripheral chemosensitivity experienced by INH patients and corrects the high daytime sensitivity of patients with D-NSH. Differences in response to CPAP between these patients can help better understand the mechanisms of perpetuation of hypertension in sleep apnoea.
引用
- Casitas R, Martínez-Cerón E, Galera R, et al. The effect of treatment for sleep apnoea on determinants of blood pressure control. Eur Respir J. 2017. PMID: 29146604. doi:10.1183/13993003.01261-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。